Product correctly added to cart.

Standards and Solutions in Compliance with Pharmacopoeias
Standards and Solutions in Compliance with Pharmacopoeias

Standards and Solutions in Compliance with Pharmacopoeias

Standards and solutions in compliance with pharmacopoeias are essential reference materials used to ensure the quality, safety, and efficacy of pharmaceutical products. This category includes a wide range of solutions and reagents that adhere to the stringent requirements set forth by various pharmacopoeias, such as the European Pharmacopoeia (EP) and the British Pharmacopoeia (BP). These standards are critical for the calibration and validation of analytical methods, ensuring that pharmaceutical products meet regulatory standards. They support a broad spectrum of applications, including the analysis of active pharmaceutical ingredients (APIs), excipients, and finished drug products. By providing consistent and reliable reference points, these standards and solutions facilitate compliance with regulatory requirements, enhance quality control processes, and ensure the production of safe and effective pharmaceuticals. Their use is indispensable in pharmaceutical research, development, and manufacturing, ensuring that products adhere to the highest quality standards.

Read more

Products of "Standards and Solutions in Compliance with Pharmacopoeias"

Sort by


See more categories

This search does not contain any category.

products per page. 4391 products on this category.

BrandProduct dataPurityPrice rangeEstimated delivery
EDQM - European Pharmacopoeia logo
Bambuterol hydrochloride CRS
REF: 41-B0250000
CAS: 81732-46-9
- - -115.00 €Tue 05 Nov 24
British Pharmacopoeia logo
Zidovudine impurity standard
REF: 47-895
CAS:
- - -205.00 €Tue 05 Nov 24
EDQM - European Pharmacopoeia logo
Procaine benzylpenicillin for peak identification A CRS
REF: 41-Y0002265
- - -115.00 €Tue 05 Nov 24
EDQM - European Pharmacopoeia logo
Imidacloprid CRS
REF: 41-Y0002028
CAS: 138261-41-3
- - -115.00 €Tue 05 Nov 24
British Pharmacopoeia logo
Cytarabine
REF: 47-383
CAS: 147-94-4
99.9%235.00 €Tue 05 Nov 24
EDQM - European Pharmacopoeia logo
First International Standard for Colistin
REF: 41-ISA_65_062
- - -115.00 €Tue 05 Nov 24
EDQM - European Pharmacopoeia logo
Methylprednisolone for system suitability A CRS
REF: 41-Y0001799
CAS: 83-43-2
- - -115.00 €Tue 05 Nov 24
British Pharmacopoeia logo
Miconazole nitrate
REF: 47-253
CAS: 22832-87-7
86.4% / 99.5%235.00 €Tue 05 Nov 24
EDQM - European Pharmacopoeia logo
Isoprenaline sulfate CRS
REF: 41-I0600000
CAS: 6078-56-4
- - -115.00 €Tue 05 Nov 24
EDQM - European Pharmacopoeia logo
Somatostatin impurity B CRS
REF: 41-Y0002280
CAS: 85734-83-4
- - -137.00 €Tue 05 Nov 24
British Pharmacopoeia logo
Leflunomide
REF: 47-1233
CAS: 75706-12-6
99.9%235.00 €Tue 05 Nov 24
EDQM - European Pharmacopoeia logo
Fenoterol hydrobromide CRS
REF: 41-F0050000
CAS: 1944-12-3
- - -115.00 €Tue 05 Nov 24
EDQM - European Pharmacopoeia logo
Yohimbine for system suitability CRS
REF: 41-Y0002376
CAS: 65-19-0
- - -152.00 €Tue 05 Nov 24
EDQM - European Pharmacopoeia logo
Hyoscine impurity A CRS
REF: 41-Y0000484
- - -115.00 €Tue 05 Nov 24
British Pharmacopoeia logo
Desogestrel
REF: 47-568
CAS: 54024-22-5
99.8%236.00 €Tue 05 Nov 24
EDQM - European Pharmacopoeia logo
Nebivolol for peak identification CRS
REF: 41-Y0002306
- - -455.00 €Tue 05 Nov 24
EDQM - European Pharmacopoeia logo
Mesna impurity C CRS
REF: 41-Y0000316
- - -115.00 €Tue 05 Nov 24
EDQM - European Pharmacopoeia logo
Saposhnikovia root for system suitability HRS
REF: 41-Y0002347
- - -115.00 €Tue 05 Nov 24
EDQM - European Pharmacopoeia logo
Oxytocin for NMR identification CRS
REF: 41-Y0002358
CAS: 50-56-6
- - -137.00 €Tue 05 Nov 24
British Pharmacopoeia logo
Naproxen
REF: 47-435
CAS: 22204-53-1
99.8%235.00 €Tue 05 Nov 24
discount label

Bambuterol hydrochloride CRS


Ref: 41-B0250000

100mg115.00 €
Estimated delivery in United States, on Tuesday 5 Nov 2024
discount label

Ref: 47-895

25mg205.00 €
Estimated delivery in United States, on Tuesday 5 Nov 2024
discount label

Ref: 41-Y0002265

15mg115.00 €
Estimated delivery in United States, on Tuesday 5 Nov 2024
discount label

Ref: 41-Y0002028

150mg115.00 €
Estimated delivery in United States, on Tuesday 5 Nov 2024
discount label

Cytarabine


Ref: 47-383

100mg235.00 €
Estimated delivery in United States, on Tuesday 5 Nov 2024
discount label

Ref: 41-ISA_65_062

75mg115.00 €
Estimated delivery in United States, on Tuesday 5 Nov 2024
discount label

Methylprednisolone for system suitability A CRS


Ref: 41-Y0001799

10mg115.00 €
Estimated delivery in United States, on Tuesday 5 Nov 2024
discount label

Miconazole nitrate


Ref: 47-253

100mg235.00 €
Estimated delivery in United States, on Tuesday 5 Nov 2024
discount label

Isoprenaline sulfate CRS


Ref: 41-I0600000

510mg115.00 €
Estimated delivery in United States, on Tuesday 5 Nov 2024
discount label

Ref: 41-Y0002280

0.01mg137.00 €
Estimated delivery in United States, on Tuesday 5 Nov 2024
discount label

Leflunomide


Ref: 47-1233

100mg235.00 €
Estimated delivery in United States, on Tuesday 5 Nov 2024
discount label

Ref: 41-F0050000

20mg115.00 €
Estimated delivery in United States, on Tuesday 5 Nov 2024
discount label

Ref: 41-Y0002376

15mg152.00 €
Estimated delivery in United States, on Tuesday 5 Nov 2024
discount label

Ref: 41-Y0000484

15mg115.00 €
Estimated delivery in United States, on Tuesday 5 Nov 2024
discount label

Desogestrel


Ref: 47-568

100mg236.00 €
Estimated delivery in United States, on Tuesday 5 Nov 2024
discount label

Ref: 41-Y0002306

15mg455.00 €
Estimated delivery in United States, on Tuesday 5 Nov 2024
discount label

Ref: 41-Y0000316

15mg115.00 €
Estimated delivery in United States, on Tuesday 5 Nov 2024
discount label

Ref: 41-Y0002347

510mg115.00 €
Estimated delivery in United States, on Tuesday 5 Nov 2024
discount label

Ref: 41-Y0002358

5mg137.00 €
Estimated delivery in United States, on Tuesday 5 Nov 2024
discount label

Naproxen


Ref: 47-435

100mg235.00 €
Estimated delivery in United States, on Tuesday 5 Nov 2024
Welcome to CymitQuimica!We use cookies to enhance your visit. We do not include advertising.

Please see our Cookies Policy for more details or adjust your preferences in "Settings".